Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ)
CNY 7.43
(-9.06%)
CNY 7.43
(-9.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 98.45 Million | 27.15 Million | 51.8 Million | 96.87 Million | 12.96 Million | 62.1 Million |
| Net Income | 34.32 Million | 43.93 Million | 1.47 Million | 19.83 Million | -122.18 Million | 35.87 Million |
| Depreciation & Amortization | 24.21 Million | 25.89 Million | 28.39 Million | 28.19 Million | 27.17 Million | 27.07 Million |
| Deferred income taxes | 108.52 Thousand | 2.37 Million | 1.02 Million | -637.91 Thousand | 3.75 Million | -53.23 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 40.98 Million | -48.37 Million | -4.77 Million | 38.82 Million | -16.11 Million | -6.08 Million |
| Other non-cash items | 445.34 | 5.69 Million | 26.7 Million | 10.01 Million | 124.08 Million | 5.22 Million |
| Investing Cash Flow | -150.23 Million | -51.03 Million | 55.2 Million | -18.18 Million | -105.11 Million | -6.78 Million |
| Investments in PPE | -5.06 Million | -2.74 Million | -2.34 Million | -11.68 Million | -18.81 Million | -8.94 Million |
| Acquisitions | 1.45 Million | 92.22 Thousand | 14.2 Thousand | 29.91 Thousand | 11.13 Thousand | 2.16 Million |
| Investment purchases | - | -92.22 Thousand | -14.2 Thousand | -29.91 Thousand | -86.31 Million | - |
| Sales/Maturities of investments | 3.37 Million | 1.61 Million | 32.5 Million | 18.5 Million | -11.13 Thousand | - |
| Other Investing Activities | -150 Million | -49.9 Million | 25.05 Million | -25 Million | 11.13 Thousand | 2.16 Million |
| Financing Cash Flow | -445.34 | -31.55 Million | 15.08 Million | -83.79 Million | 99.51 Million | -22.33 Million |
| Debt repayment | - | -31.1 Million | -15 Million | -135 Million | -19 Million | -58 Million |
| Dividends payments | -445.34 | -454.16 Thousand | -1.01 Million | -3.79 Million | -3.45 Million | -1.33 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -445.00 | - | 31.1 Million | 55 Million | 121.96 Million | 37 Million |
| Accounts receivables | 118.36 Million | -86.45 Million | 9.62 Million | 9.02 Million | -8.29 Million | 22.88 Million |
| Accounts payables | -75.13 Million | 44.11 Million | -14.65 Million | 27.89 Million | -6.67 Million | -19.99 Million |
| Inventory | -2.35 Million | -8.4 Million | -776.63 Thousand | 2.54 Million | -4.89 Million | -8.91 Million |
| Other working capital | -75.02 Million | 2.37 Million | 1.02 Million | -637.91 Thousand | 3.75 Million | 2.83 Million |
| Cash at beginning of period | 183.85 Million | 239.29 Million | 117.19 Million | 122.3 Million | 114.94 Million | 81.96 Million |
| Cash at end of period | 132.07 Million | 183.85 Million | 239.29 Million | 117.19 Million | 122.3 Million | 114.94 Million |
| Capital Expenditure | -5.06 Million | -2.74 Million | -2.34 Million | -11.68 Million | -18.81 Million | -8.94 Million |
| Effect of forex changes on cash | - | 0.73 | 1.00 | 0.55 | 0.06 | -0.40 |
| Net cash flow / Change in cash | -51.78 Million | -55.43 Million | 122.09 Million | -5.11 Million | 7.36 Million | 32.98 Million |
| Free Cash Flow | 93.39 Million | 24.41 Million | 49.45 Million | 85.19 Million | -5.85 Million | 53.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 485.55 Thousand | 5.18 Million | 9.41 Million | 34.32 Million | 6.65 Million | 6.06 Million |
| Depreciation & Amortization | 5.01 Million | 5.01 Million | 24.21 Million | 24.21 Million | -12.43 Million | 6.23 Million |
| Deferred income taxes | - | - | - | 108.52 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 17.64 Million | - | 116 Million | 40.98 Million | -46.21 Million | 46.21 Million |
| Other non-cash items | 15.87 Million | 7.44 Million | -103.44 Million | 445.34 | 64.21 Million | -16.26 Million |
| Investing Cash Flow | 70.17 Million | -27.62 Million | -19.76 Million | -150.23 Million | -119.73 Million | -9.8 Million |
| Investments in PPE | -12.93 Million | -8.52 Million | -1.68 Million | -5.06 Million | -1 Million | -1.04 Million |
| Acquisitions | - | 702.5 Thousand | 182.95 Thousand | 1.45 Million | 1.26 Million | 140 Million |
| Investment purchases | - | - | - | - | 140 Million | -140 Million |
| Sales/Maturities of investments | 3.1 Million | 191.25 Thousand | 1.73 Million | 3.37 Million | -130 Million | 1.24 Million |
| Other Investing Activities | 80 Million | -20 Million | -20 Million | -150 Million | -129.99 Million | -9.99 Million |
| Financing Cash Flow | -25.4 Million | -86.07 | -445.00 | -445.34 | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -25.4 Million | -86.07 | - | -445.34 | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -25.4 Million | -86.00 | -445.00 | -445.00 | - | - |
| Accounts receivables | 31.57 Million | - | 118.36 Million | 118.36 Million | -45.21 Million | 45.21 Million |
| Accounts payables | - | - | - | -75.13 Million | - | - |
| Inventory | -13.93 Million | - | -2.35 Million | -2.35 Million | -1 Million | 1 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 117.06 Million | 132.07 Million | 105.64 Million | 183.85 Million | 213.16 Million | 181.96 Million |
| Cash at end of period | 170.08 Million | 117.06 Million | 132.07 Million | 132.07 Million | 105.64 Million | 213.16 Million |
| Capital Expenditure | -12.93 Million | -8.52 Million | -1.68 Million | -5.06 Million | -1 Million | -1.04 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 53.01 Million | -15 Million | 26.42 Million | -51.78 Million | -107.51 Million | 31.2 Million |
| Free Cash Flow | -1.58 Million | 4.1 Million | 44.5 Million | 93.39 Million | 11.21 Million | 41.2 Million |
8MI
2723
8093
6803
PHOENIXLTD
PTSP